HRT Alternatives. For Women Who Can’t or Won’t Use Hormone Therapy.

Effective non-hormonal menopause treatments exist. For women with a personal history of breast cancer, recent VTE, or simply a preference against hormone therapy, FDA-approved and evidence-based off-label options can deliver meaningful relief. This page summarizes what works, what doesn’t, and how Kindr providers prescribe non-hormonal care.

Who needs HRT alternatives

• Personal history of breast or estrogen-sensitive cancer.
• History of venous thromboembolism or stroke.
• Active liver disease or undiagnosed vaginal bleeding.
• Personal preference against hormone therapy.

FDA-approved non-hormonal options

Fezolinetant (Veozah) is a neurokinin 3 receptor antagonist that targets the KNDy neurons in the hypothalamus driving hot flashes. Trials showed ~60% reduction in moderate-to-severe vasomotor symptoms. Paroxetine 7.5 mg (Brisdelle) is a low-dose SSRI and the only medication FDA-approved specifically for vasomotor symptoms. It reduces hot flashes by 30–60%.

Off-label but evidence-based

• Venlafaxine (SNRI) — strong evidence for VMS reduction, often at 37.5–75 mg.
• Escitalopram — modest VMS effect, useful when mood symptoms co-occur.
• Gabapentin — particularly effective for nighttime hot flashes; sedating.
• Clonidine — older option; limited use due to side effects.

Non-prescription options

Soy isoflavones, black cohosh, and evening primrose have weak evidence; some women find subjective relief, but trial data are inconsistent. CBT for hot flashes (cognitive behavioral therapy) has reproducible (modest) reductions in symptom distress and is well tolerated.

Vaginal estrogen — a special case

Low-dose vaginal estrogen (cream, ring, or tablet) treats genitourinary syndrome of menopause locally with minimal systemic absorption. It is generally considered acceptable for many women in whom systemic HRT is not — including some breast cancer survivors after discussion with their oncologist. ACOG explicitly distinguishes systemic vs vaginal estrogen risk.

How Kindr approaches non-HRT care

Kindr providers prescribe FDA-approved and off-label non-hormonal options based on your symptom profile, history, and preferences. Combination strategies (e.g., gabapentin at night + venlafaxine during the day) are common and effective.

FAQ

Clinical sources

• FDA — Veozah (fezolinetant) approval
• FDA — Brisdelle (paroxetine 7.5 mg) label
• NAMS 2022 Hormone Therapy Position Statement
• ACOG — Hormone Therapy in Menopause
• Freedman RR — Menopausal hot flashes: mechanisms, endocrinology, treatment

Related HRT guides

Explore more

• Menopause HRT service overview
• Pricing plans
• Free symptom checker
• All HRT medications
• Estrogen patch guide (Climara, Vivelle-Dot, Minivelle)
• Estrogen cream & vaginal estrogen guide
• Bioidentical hormones explained

Information on this page is for educational purposes only. Prescription medications require clinical evaluation and provider approval. Individual results vary. Not an emergency service.